J

Japan Tissue Engineering Co Ltd
TSE:7774

Watchlist Manager
Japan Tissue Engineering Co Ltd
TSE:7774
Watchlist
Price: 435 JPY -3.33% Market Closed
Market Cap: 17.7B JPY
Have any thoughts about
Japan Tissue Engineering Co Ltd?
Write Note

Japan Tissue Engineering Co Ltd
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Japan Tissue Engineering Co Ltd
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
J
Japan Tissue Engineering Co Ltd
TSE:7774
Net Issuance of Common Stock
-ÂĄ3k
CAGR 3-Years
47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Net Issuance of Common Stock
ÂĄ4.8B
CAGR 3-Years
53%
CAGR 5-Years
13%
CAGR 10-Years
1%
PeptiDream Inc
TSE:4587
Net Issuance of Common Stock
-ÂĄ143k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharma Foods International Co Ltd
TSE:2929
Net Issuance of Common Stock
-ÂĄ999m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Net Issuance of Common Stock
ÂĄ3.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Japan Tissue Engineering Co Ltd
Glance View

Market Cap
17.7B JPY
Industry
Biotechnology

Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. The company is headquartered in Gamagori-Shi, Aichi-Ken and currently employs 200 full-time employees. The company went IPO on 2007-12-21. The firm operates its business in two segments. The TEP segment is engaged in the research and development of self-cultured epidermis, self-cultured cartilages and self-cultured corneal epithelium for medical institutions. The Research and Development Supports segment is engaged in the development, manufacture and sale of laboratory human cultured tissues based on tissue engineering technology and manufacturing know-how for cosmetic and pharmaceutical product manufacturers.

Intrinsic Value
376.39 JPY
Overvaluation 13%
Intrinsic Value
Price
J

See Also

What is Japan Tissue Engineering Co Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
-3k JPY

Based on the financial report for Sep 30, 2024, Japan Tissue Engineering Co Ltd's Net Issuance of Common Stock amounts to -3k JPY.

What is Japan Tissue Engineering Co Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 3Y
47%

The average annual Net Issuance of Common Stock growth rates for Japan Tissue Engineering Co Ltd have been 47% over the past three years .

Back to Top